Keyword Index
Browse for an article via relevant keywords across our entire electronic archive
Search results for: O
Results 81 - 90 of 186 shown below
OPS
S Pahernik, A G Harris, M Schmitt-Sody, S Krasnici, A E Goetz, M Dellian and K Messmer
Orthogonal polarisation spectral imaging as a new tool for the assessment of antivascular tumour treatment in vivo: a validation study
doi:10.1038/sj.bjc.6600318
Abstract | Full article | PDF
optic pathway glioma
E Lacaze, V Kieffer, A Streri, C Lorenzi, E Gentaz, J-L Habrand, G Dellatolas, C Kalifa and J Grill
Neuropsychological outcome in children with optic pathway tumours when first-line treatment is chemotherapy
doi:10.1038/sj.bjc.6601410
Abstract | Full article | PDF
optical dosimetry
B W Pogue, T Momma, H C Wu and T Hasan
Transient absorption changes in vivo during photodynamic therapy with pulsed-laser light
doi:10.1038/sj.bjc.6690361
OR isoforms
L C Murphy, E Leygue, Y Niu, L Snell, S-M Ho and P H Watson
Relationship of coregulator and oestrogen receptor isoform expression to de novo tamoxifen resistance in human breast cancer
doi:10.1038/sj.bjc.6600654
Abstract | Full article | PDF
oral
R Pacella-Norman, M I Urban, F Sitas, H Carrara, R Sur, M Hale, P Ruff, M Patel, R Newton, D Bull and V Beral
Risk factors for oesophageal, lung, oral and laryngeal cancers in black South Africans
doi:10.1038/sj.bjc.6600338
Abstract | Full article | PDF
-
C J Twelves and J Cassidy
Which endpoints should we use in evaluating the use of novel fluoropyrimidine regimens in colorectal cancer?
doi:10.1038/sj.bjc.6600341
Abstract | Full article | PDF
-
P H Jones, R D Burnett, I Fainaru, P Nadolny, P Walker, Z Yu, D Tang-Liu, T S Ganesan, D C Talbot, A L Harris and G J S Rustin
A phase 1 study of tazarotene in adults with advanced cancer
doi:10.1038/sj.bjc.6601169
Abstract | Full article | PDF
-
A Z Reznick, O Hershkovich and R M Nagler
Saliva – a pivotal player in the pathogenesis of oropharyngeal cancer
advance online publication, 2004-05-25 00:00:00.000;
doi:10.1038/sj.bjc.6601869
Abstract | Full article | PDF
-
M J A de Jonge, S Kaye, J Verweij, C Brock, S Reade, M Scurr, L van Doorn, C Verheij, W Loos, C Brindley, P Mistry, M Cooper and I Judson
Phase I and pharmacokinetic study of XR11576, an oral topoisomerase I and II inhibitor, administered on days 1–5 of a 3-weekly cycle in patients with advanced solid tumours
advance online publication, 2004-09-28 00:00:00.000;
doi:10.1038/sj.bjc.6602178
Abstract | Full article | PDF
-
G Bradley, S Tremblay, J Irish, C MacMillan, G Baker, P Gullane and S Benchimol
The expression of p53-induced protein with death domain (Pidd) and apoptosis in oral squamous cell carcinoma
advance online publication, 2007-04-17 00:00:00.000;
doi:10.1038/sj.bjc.6603745
Abstract | Full article | PDF
-
D I Jodrell, A Bowman, R Rye, B Byrne, A Boddy, I Rafi, A Johnston and N J Clendeninn
A phase I study of the lipophilic thymidylate synthase inhibitor Thymitaq™ (nolatrexed dihydrochloride) given by 10-day oral administration
doi:10.1038/sj.bjc.6690146
-
V M M Herben, H Rosing, W W ten Bokkel Huinink, D M van Zomeren, D Batchelor, E Doyle, F D Beusenberg, J H Beijnen and J H M Schellens
Oral topotecan: bioavailability and effect of food co-administration
doi:10.1038/sj.bjc.6690532
-
M Brada, I Judson, P Beale, S Moore, P Reidenberg, P Statkevich, M Dugan, V Batra and D Cutler
Phase I dose-escalation and pharmacokinetic study of temozolomide (SCH 52365) for refractory or relapsing malignancies
doi:10.1038/sj.bjc.6690802
-
R C F Leonard
Oral fluoropyrimidines among the new drugs for patients with metastatic breast cancer
doi:10.1054/bjoc.2001.1819
oral administration
A Kuin, M Rutgers and L A Smets
Bioavailability and toxicity after oral administration of m-iodobenzylguanidine (MIBG)
doi:10.1038/sj.bjc.6690128
-
M M Malingré, J H Beijnen, H Rosing, F J Koopman, R C Jewell, E M Paul, W W Ten Bokkel Huinink and J H M Schellens
Co-administration of GF120918 significantly increases the systemic exposure to oral paclitaxel in cancer patients
doi:10.1054/bjoc.2000.1543
-
M M Malingré, J H M Schellens, O Van Tellingen, M Ouwehand, H A Bardelmeijer, H Rosing, F J Koopman, M E Schot, W W Ten Bokkel Huinink and J H Beijnen
The co-solvent Cremophor EL limits absorption of orally administered paclitaxel in cancer patients
doi:10.1054/bjoc.2001.2118
oral antibiotics
H E Innes, D B Smith, S M O'Reilly, P I Clark, V Kelly and E Marshall
Oral antibiotics with early hospital discharge compared with in-patient intravenous antibiotics for low-risk febrile neutropenia in patients with cancer: a prospective randomised controlled single centre study
doi:10.1038/sj.bjc.6600993
Abstract | Full article | PDF
-
H Innes, L Billingham, C Gaunt, N Steven and E Marshall
Management of febrile neutropenia in the United Kingdom: time for a national trial?
doi:10.1038/sj.bjc.6602872
Abstract | Full article | PDF
oral cancer
I-H Chen, J T Chang, C-T Liao, H-M Wang, L-L Hsieh and A-J Cheng
Prognostic significance of EGFR and Her-2 in oral cavity cancer in betel quid prevalent area cancer prognosis
doi:10.1038/sj.bjc.6601171
Abstract | Full article | PDF
-
S Friis, A Poulsen, L Pedersen, J A Baron and H T Sørensen
Use of nonsteroidal anti-inflammatory drugs and risk of oral cancer: a cohort study
advance online publication, 2006-07-25 00:00:00.000;
doi:10.1038/sj.bjc.6603250
Abstract | Full article | PDF
-
M K Kang, R H Kim, S J Kim, F K Yip, K-H Shin, G P Dimri, R Christensen, T Han and N-H Park
Elevated Bmi-1 expression is associated with dysplastic cell transformation during oral carcinogenesis and is required for cancer cell replication and survival
advance online publication, 2006-12-19 00:00:00.000;
doi:10.1038/sj.bjc.6603529
Abstract | Full article | PDF
-
D R Moles, S Fedele, P M Speight, S R Porter and I dos Santos Silva
Oral and pharyngeal cancer in South Asians and non-South Asians in relation to socioeconomic deprivation in South East England
advance online publication, 2008-01-22 00:00:00.000;
doi:10.1038/sj.bjc.6604191
Abstract | Full article | PDF
-
D Wangsa, M Ryott, E Åvall-Lundqvist, F Petersson, G Elmberger, J Luo, T Ried, G Auer and E Munck-Wikland
Ki-67 expression predicts locoregional recurrence in stage I oral tongue carcinoma
advance online publication, 2008-09-02 00:00:00.000;
doi:10.1038/sj.bjc.6604633
Abstract | Full article | PDF
-
P A Jayalekshmi, P Gangadharan, S Akiba, R R K Nair, M Tsuji and B Rajan
Tobacco chewing and female oral cavity cancer risk in Karunagappally cohort, India
doi:10.1038/sj.bjc.6604907
Abstract | Full article | PDF
-
A Torres-Rendon, S Roy, G T Craig and P M Speight
Expression of Mcm2, geminin and Ki67 in normal oral mucosa, oral epithelial dysplasias and their corresponding squamous-cell carcinomas
advance online publication, 2009-03-17 00:00:00.000;
doi:10.1038/sj.bjc.6604967
Abstract | Full article | PDF
-
H Hasegawa, W Kakuguchi, T Kuroshima, T Kitamura, S Tanaka, Y Kitagawa, Y Totsuka, M Shindoh and F Higashino
HuR is exported to the cytoplasm in oral cancer cells in a different manner from that of normal cells
doi:10.1038/sj.bjc.6605084
Abstract | Full article | PDF
-
M Partridge, G Emilion, S Pateromichelakis, R A'Hern, G Lee, E Phillips and J Langdon
The prognostic significance of allelic imbalance at key chromosomal loci in oral cancer
doi:10.1038/sj.bjc.6690290
-
H Kawamata, D Uchida, K Nakashiro, S Hino, F Omotehara, H Yoshida and M Sato
Haematogenous cytokeratin 20 mRNA as a predictive marker for recurrence in oral cancer patients
doi:10.1038/sj.bjc.6690377
-
M Sartor, H Steingrimsdottir, F Elamin, J Gäken, S Warnakulasuriya, M Partridge, N Thakker and N W Johnson
Role of p16/MTS1, cyclin D1 and RB in primary oral cancer and oral cancer cell lines
doi:10.1038/sj.bjc.6690505
-
C Bosetti, E Negri, S Franceschi, E Conti, F Levi, F Tomei and C La Vecchia
Risk factors for oral and pharyngeal cancer in women: a study from Italy and Switzerland
doi:10.1054/bjoc.1999.0900
-
M N Shiu, T H H Chen, S H Chang and L J Hahn
Risk factors for leukoplakia and malignant transformation to oral carcinoma: a leukoplakia cohort in Taiwan
doi:10.1054/bjoc.2000.1208
-
R Talamini, S Vaccarella, F Barbone, A Tavani, C La Vecchia, R Herrero, N Muñoz and S Franceschi
Oral hygiene, dentition, sexual habits and risk of oral cancer
doi:10.1054/bjoc.2000.1398
-
N Yamamoto, K Uzawa, T Yakushiji, T Shibahara, H Noma and H Tanzawa
Analysis of the ANA gene as a candidate for the chromosome 21q oral cancer susceptibility locus
doi:10.1054/bjoc.2000.1656
-
A T Tandle, V Sanghvi and D Saranath
Determination of p53 genotypes in oral cancer patients from India
doi:10.1054/bjoc.2000.1674
-
L Fernandez Garrote, R Herrero, R M Ortiz Reyes, S Vaccarella, J Lence Anta, L Ferbeye, N Muñoz and S Franceschi
Risk factors for cancer of the oral cavity and oro-pharynx in Cuba
doi:10.1054/bjoc.2000.1825
oral carcinoma
D I Conway, D H Brewster, P A McKinney, J Stark, A D McMahon and L M D Macpherson
Widening socio-economic inequalities in oral cancer incidence in Scotland, 1976–2002
doi:10.1038/sj.bjc.6603621
Abstract | Full article | PDF
-
I Cruz, C J L M Meijer, J M M Walboomers, P J F Snijders and I Van der Waal
Lack of MHC class I surface expression on neoplastic cells and poor activation of the secretory pathway of cytotoxic cells in oral squamous cell carcinomas
doi:10.1038/sj.bjc.6690780
oral cavity
H Scherübl, B von Lampe, S Faiss, P Däubler, P Bohlmann, T Plath, H-D Foss, H Scherer, A Strunz, B Hoffmeister, H Stein, M Zeitz and E-O Riecken
Screening for oesophageal neoplasia in patients with head and neck cancer
doi:10.1038/sj.bjc.6600018
Abstract | Full article | PDF
-
I S Scott, E Odell, P Chatrath, L S Morris, R J Davies, S L Vowler, R A Laskey and N Coleman
A minimally invasive immunocytochemical approach to early detection of oral squamous cell carcinoma and dysplasia
doi:10.1038/sj.bjc.6603066
Abstract | Full article | PDF
